Mapping PD-1 immunoreceptor signalling pathways

被引：0
|
作者：
Kreileder, M. [1 ]
Nabhan, M. [1 ]
Egan, D. [1 ]
Zhernovkov, V. [1 ]
Glennon, K. [2 ]
Barrett, I. [3 ]
Bendtsen, C. [3 ]
Dovedi, S. [3 ]
Valge-Archer, V. [3 ]
Wilkinson, R. [3 ]
Brennan, D. [1 ,2 ]
Kolch, W. [1 ]
机构：
[1] Univ Coll Dublin, Syst Biol Ireland, Precis Oncol Ireland, Belfield, Ireland
[2] Mater Misericoridae Univ Hosp, Catherine McAuley Res Ctr, Dublin, Ireland
[3] AstraZeneca, Cambridge Biomed Campus, Cambridge, England
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2022年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P 85
引用
收藏
页码：125 / 125
页数：1
相关论文
共 50 条
  • [21] PD-1 in RA
    Kristjansdottir, H.
    Grondal, G.
    Erlendsson, K.
    Steinsson, K.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 : 14 - 14
  • [22] The PD-1 Interactome
    Wang, Qi
    Bardhan, Kankana
    Boussiotis, Vassiliki A.
    Patsoukis, Nikolaos
    ADVANCED BIOLOGY, 2021, 5 (09):
  • [23] Impeding PD-1
    Scudellari, Megan
    SCIENTIST, 2008, 22 (10): : 57 - 58
  • [24] PD-1 and Autoimmunity
    Kasagi, Shimpei
    Kawano, Seiji
    Kumagai, Shunichi
    CRITICAL REVIEWS IN IMMUNOLOGY, 2011, 31 (04) : 265 - 295
  • [25] Tumor intrinsic PD-1/PD-L1 signalling induces mesenchymal to epithelial transition in canine osteosarcoma cells
    Parys, Maciej
    Nekulova, Marta
    Vojtesek, Borivoj
    Faktor, Jakub
    Lima, Ana
    Hupp, Theodore
    CANCER RESEARCH, 2018, 78 (13)
  • [26] PD-1 Blockers
    Wolchok, Jedd D.
    CELL, 2015, 162 (05) : 937 - 937
  • [27] CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition
    Buchbinder, Elizabeth I.
    Desai, Anupam
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (01): : 98 - 106
  • [28] Inflammasomes/IL-1 pathways in myeloid cells modulate PD-1/PD-L1 checkpoint molecules
    Guo, Beichu
    Zhang, Jinyu
    Fu, Shunjun
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [29] Downregulation of cellular immune responses to porcine xenoantigen by targeting PD-1/PD-ligand pathways
    Plege, Annegret
    Lieke, Thorsten
    Roemermann, Dorothee
    Beer, Lilli
    Schwinzer, Reinhard
    XENOTRANSPLANTATION, 2009, 16 (05) : 386 - 386
  • [30] Targeting PD-1/PD-L1 in tumor immunotherapy: Mechanisms and interactions with host growth regulatory pathways
    Shen, Songyu
    Hong, Yihan
    Huang, Jiajun
    Qu, Xiaosheng
    Sooranna, Suren Rao
    Lu, Sheng
    Li, Tian
    Niu, Bing
    CYTOKINE & GROWTH FACTOR REVIEWS, 2024, 79 : 16 - 28
12345